Ibnsina Pharma (EGX:ISPH)

Market Cap	6.69B
Revenue (ttm)	55.84B
Net Income (ttm)	614.56M
Shares Out	1.01B
EPS (ttm)	n/a
PE Ratio	10.89
Forward PE	10.54
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,925,986
Average Volume	5,164,742
Open	6.65
Previous Close	6.65
Day's Range	6.62 - 6.71
52-Week Range	2.14 - 7.59
Beta	0.41
RSI	54.34
Earnings Date	Feb 27, 2025

About Ibnsina Pharma

Ibnsina Pharma operates as a pharmaceutical distributor in Egypt. The company offers pharmaceutical and cosmetics products to private and public-sector customers, including retail chains, independent pharmacies, wholesalers, and hospitals and healthcare institutions. It also provides warehousing and logistic services for its suppliers; marketing solutions; importation and packaging services; and market research and analysis services. The company was founded in 2001 and is headquartered in El Obour City, Egypt.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2001
• Employees: 5,500
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: ISPH

Financial Performance

In 2024, Ibnsina Pharma's revenue was 55.84 billion, an increase of 64.49% compared to the previous year's 33.95 billion. Earnings were 614.56 million, an increase of 254.95%.